Cancer Research UK yesterday announced the recipients of this year's Cancer Research UK Prizes at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
World-leading cell signalling expert Professor Chris Marshall, based at The Institute of Cancer Research, received the Cancer Research UK Lifetime Achievement in Cancer Research Prize. His findings have transformed our understanding of the disease and paved the way for a new range of treatments that target signalling in cancer cells, one of which is currently showing great promise in treating skin cancers.
The two recipients of the Future Leaders in Cancer Research Prize were Professor Thomas Brunner at the Gray Institute of Radiation Oncology and Biology and Dr Sarah Martin at the Barts Cancer Institute at Queen Mary University of London. The Future Leaders in Cancer Research Prize recognises early career researchers who are already showing the potential to become world class leaders in their field.
A team of researchers from across Manchester, led by Professor Caroline Dive and comprising Professor Malcolm Ranson, Dr Fiona Blackhall and Professor Andrew Hughes, were awarded the Prize for Translational Cancer Research. Their work has transformed the use of biomarkers in clinical trials and brought together academic and industrial researchers in the translational arena.
The Cancer Research UK Prizes recognise world leading cancer researchers and the scientists of tomorrow.
Dr Harpal Kumar, Chief Executive of Cancer Research UK, said: "We're delighted to announce the recipients of this year's Cancer Research UK prizes. Their work has improved our knowledge of the disease and opened new opportunities to treat cancer. As a result, more patients will survive cancer in the future."
Increased emotional sensitivity linked to previous COVID-19 infection, new research suggests